R
Raghu Kalluri
Researcher at University of Texas MD Anderson Cancer Center
Publications - 325
Citations - 89851
Raghu Kalluri is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Angiogenesis. The author has an hindex of 115, co-authored 306 publications receiving 71127 citations. Previous affiliations of Raghu Kalluri include Beth Israel Deaconess Medical Center & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
Basement membrane derived fibulin-1 and fibulin-5 function as angiogenesis inhibitors and suppress tumor growth.
Liang Xie,Kristin Palmsten,Brian MacDonald,Mark W. Kieran,Scott Potenta,Sylvia Vong,Raghu Kalluri +6 more
TL;DR: Fibulin-1 suppression of HT1080 tumor growth is associated with diminished angiogenesis and also enhanced apoptosis of endothelial cells and tumor cells, and fibulin-5 inhibits tumorAngiogenesis with a minimal anti-apoptotic affect.
Journal ArticleDOI
Goodpasture syndrome involving overlap with Wegener's granulomatosis and anti-glomerular basement membrane disease
Raghu Kalluri,Raghu Kalluri,Kevin E.C. Meyers,András Mogyorósi,Michael P. Madaio,Eric G. Neilson +5 more
TL;DR: The patient reported here had the unusual combination of c-ANCA antibodies with anti-GBM disease, and this association raises complex questions regarding the pathogenesis of this type of renal injury.
Journal Article
Antineoplastic effects of chemotherapeutic agents are potentiated by NM-3, an inhibitor of angiogenesis
Corinne L. Reimer,Naoki Agata,Jennifer Tammam,Michael Bamberg,William M. Dickerson,George D. Kamphaus,Susan L. Rook,Michael Milhollen,Robert Fram,Raghu Kalluri,Donald Kufe,Surender Kharbanda +11 more
TL;DR: NM-3 is a well-tolerated angiogenesis inhibitor that significantly increases the efficacy of existing antineoplastic agents and shows synergistic antiproliferative activity when treated with NM-3 in combination with 5-fluorouracil.
Journal Article
NM-3, an Isocoumarin, Increases the Antitumor Effects of Radiotherapy without Toxicity
Rabih M. Salloum,Nora Jaskowiak,Helena J. Mauceri,Saraswathy Seetharam,Michael A. Beckett,Ann Koons,Danielle M. Hari,Vinay K. Gupta,Corinne L. Reimer,Raghu Kalluri,Mitchell C. Posner,Samuel Hellman,Donald Kufe,Ralph R. Weichselbaum +13 more
TL;DR: The present studies demonstrate that NM-3 is cytotoxic to human umbilical vein endothelial cells (HUVECs) but not to Lewis lung carcinoma (LLC) cells nor Seg-1, esophageal adenocarcinoma cells, in clonogenic survival assays.
Journal ArticleDOI
Summary of the ISEV workshop on extracellular vesicles as disease biomarkers, held in Birmingham, UK, during December 2017
Aled Clayton,Dominik Buschmann,J. Brian Byrd,David R. F. Carter,Lesley Cheng,Carolyn C. Compton,George G. Daaboul,Andrew Devitt,Juan M. Falcón-Pérez,Chris Gardiner,Dakota Gustafson,Paul Harrison,Clemens Helmbrecht,An Hendrix,Andrew F. Hill,Andrew M. Hoffman,Jennifer Jones,Raghu Kalluri,Ji Yoon Kang,Benedikt Kirchner,Cecilia Lässer,Charlotte Lawson,Metka Lenassi,Carina Levin,Alicia Llorente,Elena S. Martens-Uzunova,Andreas Möller,Luca Musante,Takahiro Ochiya,Ryan C. Pink,Hidetoshi Tahara,Marca H. M. Wauben,Jason P. Webber,Joshua A. Welsh,Kenneth W. Witwer,Hang Yin,Rienk Nieuwland +36 more
TL;DR: The conclusion of the ISEV Workshop on extracellular vesicle biomarkers was that more effort focused on pre-analytical issues and benchmarking of isolation methods is needed to strengthen collaborations and advance more effective biomarkers.